These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12647637)

  • 1. Adenocarcinoma of unknown primary site.
    Song SY; Kim WS; Lee HR; Jung HS; Oh SY; Kim JH; Kim K; Nam EM; Oh YR; Jung CW; Yoon SS; Im YH; Lee HG; Kang WK; Park CH; Park K
    Korean J Intern Med; 2002 Dec; 17(4):234-9. PubMed ID: 12647637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
    Greco FA; Johnson DH; Hainsworth JD
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):14-8. PubMed ID: 1492223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.
    Hainsworth JD; Johnson DH; Greco FA
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):54-7; discussion 58. PubMed ID: 1384145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.
    Falkson CI; Cohen GL
    Oncology; 1998; 55(2):116-21. PubMed ID: 9499185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
    Hainsworth JD; Johnson DH; Greco FA
    J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.
    Karapetis CS; Yip D; Virik K; Strickland A; Ryder K; Cowling M; Harper PG
    Med Oncol; 2001; 18(1):23-32. PubMed ID: 11778966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site.
    Hainsworth JD; Dial TW; Greco FA
    Am J Clin Oncol; 1988 Apr; 11(2):138-45. PubMed ID: 2451881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer.
    Mukai H; Katsumata N; Ando M; Watanabe T
    Am J Clin Oncol; 2010 Feb; 33(1):32-5. PubMed ID: 19786850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
    Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
    van der Gaast A; Verweij J; Planting AS; Hop WC; Stoter G
    J Clin Oncol; 1995 Jul; 13(7):1720-5. PubMed ID: 7541451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.
    Shin DY; Choi YH; Lee HR; Na II; Yuh YJ; Kim BS; Chung IJ; Bae WK; Shim HJ; Song EK; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):163-8. PubMed ID: 26589790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
    Greco FA; Gray J; Burris HA; Erland JB; Morrissey LH; Hainsworth JD
    Cancer J; 2001; 7(3):203-12. PubMed ID: 11419028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unknown primary adenocarcinomas: a single-center experience.
    Uzunoglu S; Erdogan B; Kodaz H; Cinkaya A; Turkmen E; Hacibekiroglu I; Sari A; Ozen A; Usta U; Cicin I
    Bosn J Basic Med Sci; 2016 Nov; 16(4):292-297. PubMed ID: 27455119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple nodules on the face and trunk in metastatic adenocarcinoma of unknown primary origin.
    Furtado S; Bhat RM; Sukumar D; Krishnamurthy SG; Rao SD; Nandakishore B
    Singapore Med J; 2011 Jul; 52(7):e163-6. PubMed ID: 21808952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
    Lenzi R; Hess KR; Abbruzzese MC; Raber MN; Ordoñez NG; Abbruzzese JL
    J Clin Oncol; 1997 May; 15(5):2056-66. PubMed ID: 9164218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients.
    Alberts AS; Falkson G; Falkson HC; van der Merwe MP
    Med Pediatr Oncol; 1989; 17(3):188-92. PubMed ID: 2747591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
    Kambhu SA; Kelsen DP; Fiore J; Niedzwiecki D; Chapman D; Vinciguerra V; Rosenbluth R
    Am J Clin Oncol; 1990 Feb; 13(1):55-60. PubMed ID: 2106257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan.
    Yakushiji S; Ando M; Yonemori K; Kohno T; Shimizu C; Katsumata N; Fujiwara Y
    Int J Clin Oncol; 2006 Dec; 11(6):421-5. PubMed ID: 17180509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.